Elie Dolgin, PHD, Science Journalist

'Remarkable' AI tool designs mRNA vaccines that are more potent and stable

Elie Dolgin • May 02, 2023

Software from Baidu Research yields jabs for COVID that have greater shelf stability and that trigger a larger antibody response in mice than conventionally designed shots.

An artificial intelligence (AI) tool that optimizes the gene sequences found in mRNA vaccines could help to create jabs with greater potency and stability that could be deployed across the globe.


Developed by scientists at the California division of Baidu Research, an AI company based in Beijing, the software borrows techniques from computational linguistics to design mRNA sequences with shapes and structures more intricate than those used in current vaccines. This enables the genetic material to persist for longer than usual. The more stable the mRNA that’s delivered to a person’s cells, the more antigens are produced by the protein-making machinery in that person’s body. This, in turn, leads to a rise in protective antibodies, theoretically leaving immunized individuals better equipped to fend off infectious diseases.


What’s more, the enhanced structural complexity of the mRNA offers improved protection against vaccine degradation.


Continue reading at Nature.

mRNA inside a lipid nanoparticle
By Elie Dolgin 03 Apr, 2024
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
Man wearing the FSYX Ocular Pressure Adjusting Pump device for glaucoma treatment.
By Elie Dolgin 22 Mar, 2024
FDA panel’s green light on glaucoma wearable device offers hope in sight.
Share by: